Myriad Genetics DEF 14A: Executive Compensation Details
Ticker: MYGN · Form: DEF 14A · Filed: Apr 9, 2025 · CIK: 899923
| Field | Detail |
|---|---|
| Company | Myriad Genetics Inc (MYGN) |
| Form Type | DEF 14A |
| Filed Date | Apr 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, proxy-statement, stock-awards
Related Tickers: MYGN
TL;DR
MYGN DEF 14A out: exec comp details for FY24, incl. stock awards for Paul Diaz.
AI Summary
Myriad Genetics Inc. filed its DEF 14A on April 9, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes information on stock awards granted to key personnel, such as Paul J. Diaz, with grant dates and fair values reported for the 2024 fiscal year.
Why It Matters
This filing provides transparency into how Myriad Genetics compensates its top executives, which can influence investor perception and corporate governance.
Risk Assessment
Risk Level: low — This is a routine annual filing (DEF 14A) providing information on executive compensation and is not indicative of immediate financial risk.
Key Players & Entities
- MYRIAD GENETICS INC (company) — Filer of the DEF 14A
- Paul J. Diaz (person) — Executive mentioned in compensation details
- 2024-12-31 (date) — Fiscal year end
- 20250409 (date) — Filing date
FAQ
What is the total compensation reported for the CEO in the Summary Compensation Table for the fiscal year ended December 31, 2024?
The provided text does not contain the specific total compensation figures for the CEO or any executive from the Summary Compensation Table for the fiscal year ended December 31, 2024. It only mentions the reporting of stock awards.
Who is listed as a member of the Board of Directors or as a Named Executive Officer in this filing?
The filing mentions 'mygn:PaulJDiazMember' and 'mygn:RBryanRiggsbeeMember' in relation to compensation data, suggesting they are key individuals, likely executives or directors.
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Proxy Statement, is filed by a company to solicit proxies from its shareholders for an upcoming shareholder meeting, typically to vote on matters such as director elections, executive compensation, and other corporate actions.
When was the fiscal year for which compensation details are being reported?
The fiscal year for which compensation details are being reported is the year ending December 31, 2024, as indicated by 'CONFORMED PERIOD OF REPORT: 20241231'.
What type of awards are specifically mentioned in the context of executive compensation for 2024?
The filing mentions 'AggregateGrantDateFairValueOfEquityAwardAmountsReportedInSummaryCompensationTableStockAwardsMember', indicating that stock awards are a key component of the reported executive compensation for 2024.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 9, 2025 by Paul J. Diaz regarding MYRIAD GENETICS INC (MYGN).